A Clonmel pharmaceutical firm that changed ownership and its name earlier this year marked the occasion by honouring employees with more than 25 years service.
And to maintain a strong local connection, the former Clonmel Chemicals is now known as Suir Pharma.
Earlier this year Stada AG, a German based company, sold their two manufacturing plants on the Waterford Road, Clonmel to Mutares AG, Germany. Mutares has rebranded and renamed the manufacturing site to Suir Pharma Ireland, to maintain its strong local Irish connection.
Suir Pharma currently employs 170 people in Clonmel and produces pharmaceuticals products for various customers across Europe and the United States. The company was originally founded in the 1970s as Clonmel Chemicals and has continued to be a proud employer/contributor to the local economy for almost 40 years.
Suir Pharma will continue to provide Contract Manufacturing and Product Development services to the Global Pharma industry. The quality of products produced are guaranteed by a vastly experienced, skilled and committed workforce at the site.
According to Managing Director, Anthony Sheehan - “Suir Pharma has been well received across Europe and the United States as we work to consolidate and grow our business under new ownership. We are well known as a manufacturing site that can handle complexity and have already started to win new business in what is a competitive market. We have two manufacturing units on the site in Clonmel and are proud that our Anti-Biotic plant is the only Independent US FDA Approved Penicillin plant in Europe”
Members of the management team are participating in the largest Trade Fair in the World for Pharmaceuticals medicines in Madrid this week to launch the company’s new entity. Local management feel very optimistic about the future of the business and look forward to contributing to the local economy for many more years to come.